47,191 Shares in Maximus, Inc. $MMS Purchased by Candriam S.C.A.

Candriam S.C.A. purchased a new position in Maximus, Inc. (NYSE:MMS) in the first quarter, HoldingsChannel reports. The fund purchased 47,191 shares of the health services provider’s stock, valued at approximately $3,218,000.

A number of other institutional investors also recently bought and sold shares of the stock. LRI Investments LLC raised its stake in Maximus by 11.9% in the first quarter. LRI Investments LLC now owns 1,833 shares of the health services provider’s stock worth $125,000 after buying an additional 195 shares in the last quarter. Vestcor Inc raised its stake in Maximus by 2.3% in the first quarter. Vestcor Inc now owns 9,877 shares of the health services provider’s stock worth $674,000 after buying an additional 223 shares in the last quarter. Cetera Investment Advisers grew its holdings in Maximus by 5.8% in the first quarter. Cetera Investment Advisers now owns 4,519 shares of the health services provider’s stock worth $308,000 after purchasing an additional 247 shares during the period. UMB Bank n.a. grew its holdings in Maximus by 70.2% in the first quarter. UMB Bank n.a. now owns 606 shares of the health services provider’s stock worth $41,000 after purchasing an additional 250 shares during the period. Finally, Nisa Investment Advisors LLC grew its holdings in Maximus by 0.7% in the first quarter. Nisa Investment Advisors LLC now owns 39,936 shares of the health services provider’s stock worth $2,723,000 after purchasing an additional 290 shares during the period. 97.21% of the stock is owned by institutional investors.

Insider Activity at Maximus

In other news, Director Gayathri Rajan sold 7,913 shares of the stock in a transaction that occurred on Friday, May 30th. The shares were sold at an average price of $72.38, for a total transaction of $572,742.94. Following the sale, the director owned 14,205 shares in the company, valued at $1,028,157.90. This represents a 35.78% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available through the SEC website. 1.60% of the stock is currently owned by insiders.

Maximus Price Performance

Shares of MMS opened at $86.9260 on Friday. The stock has a market cap of $4.90 billion, a PE ratio of 16.01 and a beta of 0.60. The company has a debt-to-equity ratio of 0.91, a quick ratio of 2.27 and a current ratio of 2.27. Maximus, Inc. has a fifty-two week low of $63.77 and a fifty-two week high of $93.94. The firm’s 50-day simple moving average is $74.51 and its two-hundred day simple moving average is $71.07.

Maximus (NYSE:MMS) last posted its quarterly earnings results on Thursday, August 7th. The health services provider reported $2.16 EPS for the quarter, beating analysts’ consensus estimates of $1.39 by $0.77. Maximus had a net margin of 5.83% and a return on equity of 24.44%. The firm had revenue of $1.35 billion for the quarter, compared to analysts’ expectations of $1.29 billion. During the same quarter in the prior year, the company posted $1.74 earnings per share. The business’s revenue for the quarter was up 2.5% on a year-over-year basis. Maximus has set its FY 2025 guidance at 7.350-7.550 EPS. Analysts anticipate that Maximus, Inc. will post 6.15 earnings per share for the current fiscal year.

Maximus Announces Dividend

The company also recently declared a quarterly dividend, which will be paid on Sunday, August 31st. Stockholders of record on Friday, August 15th will be issued a dividend of $0.30 per share. The ex-dividend date is Friday, August 15th. This represents a $1.20 dividend on an annualized basis and a dividend yield of 1.4%. Maximus’s dividend payout ratio is presently 22.10%.

Analysts Set New Price Targets

Separately, Wall Street Zen cut shares of Maximus from a “buy” rating to a “hold” rating in a report on Thursday, May 15th. One analyst has rated the stock with a Buy rating, According to data from MarketBeat, Maximus presently has an average rating of “Buy” and a consensus target price of $90.00.

About Maximus

Maximus, Inc operates as a provider of government services in the United States and internationally. It operates through three segments: U.S. Federal Services, U.S. Services, and Outside the U.S. The U.S. Services segment offers program eligibility support and enrollment; centralized multilingual customer contact centers, multichannel, and digital self-service options for enrollment; application assistance and independent health plan choice counseling; beneficiary outreach, education, eligibility, enrollment, and redeterminations; and person-centered independent disability, long-term sick, and other health assessments.